PeerView Internal Medicine CME/CNE/CPE Audio Podcast
Podcast image
Sharon J. Sha, MD, MS - Implementing Amyloid-Targeting Treatment for Early AD: Strategies for Overcoming Real-World Challenges
57 mins; May 20, 2025
Sia Daneshmand, MD - Putting Precision Into Practice for Bladder Cancer Treatment: Insights for Individualized Care Across the Disease Continuum
86 hours 57 mins; May 16, 2025
Sara M. Tinsley-Vance, PhD, APRN, AOCN - Partners in the Myelofibrosis Journey: Nurse-Patient Alliances for JAKi Standards and Emerging Therapeutics
88 hours 12 mins; May 12, 2025
Brenda L. Tesini, MD, Charles Vega, MD, FAAFP - Primary Care at the Center of RSV Prevention: Community-Focused Strategies to Foster Trust and Vaccine Acceptance
63 hours 36 mins; May 08, 2025
Jonathan S. Appelbaum, MD, FACP, AAHIVS - Defining and Delivering Person-Centric HIV Care in Key Populations
46 mins; May 08, 2025
Sharon J. Sha, MD, MS - Taking the Lead in Timely Diagnosis of AD: Incorporating Biomarkers Into Routine Patient Care
83 hours 47 mins; May 08, 2025
Colleen F. Kelley, MD, MPH - Progressing PrEP: Latest PrEP Advances to Prevent HIV Transmissions
43 mins; May 06, 2025
Professor Melanie Davies - Seeing Beyond the Numbers in Type 2 Diabetes: Empowering Patients for Optimal Weight and Glycaemic Management
59 mins; May 06, 2025
Prof. Nick Fox - Exploring the Promise of Biomarkers and ATTs in Diagnosing and Treating Early Symptomatic Alzheimer's Disease: Key Takeaways From AD/PD 2025 and AAN 2025
32 mins; May 06, 2025
Milind Desai, MD, MBA, FACC, FAHA, FESC / Anjali Tiku Owens, MD - Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data
50 mins; May 06, 2025
Kathleen N. Moore, MD, MS - A New Era in Treating Advanced Ovarian Cancer: Practical Tips for Maximizing the Use of PARP Inhibitors, Immunotherapy, and ADCs
64 hours 16 mins; April 24, 2025
Haydar Frangoul, MD, MS, Julie Kanter, MD - Innovation Takes Shape in SCD: Rewriting Management Principles With Gene Therapy and Revisiting the Role of HCT
57 mins; April 09, 2025
Olalekan Oluwole, MBBS, MPH - Unlocking Efficacy, Expanding Access to CAR-T in Lymphoma and Myeloma: From Practice-Changing Evidence to Real-World and Outpatient Experiences
59 mins; April 09, 2025
Zachariah DeFilipp, MD, Betty K. Hamilton, MD - The Good, the Bad, and the GVHD: Leveraging Modern Therapeutics to Improve Post-Transplant Outcomes
57 mins; April 09, 2025
Anna Chodos, MD, MPH - Brain Health Essentials: Strategies for Adapting Clinical Practice and Workflows to Optimize Cognitive Functioning in an Aging Population
60 hours 37 mins; April 09, 2025
Eleonora Lad, MD, PhD - Improving the Patient Experience in Geographic Atrophy: Are You Putting the Latest Advances Into Practice?
47 mins; April 01, 2025
Robert (Bob) J. Fox, MD / Jiwon Oh, MD, PhD, FRCPC - BTK Inhibition as an MS Treatment Strategy: Targeting Smoldering Neuroinflammation
52 mins; April 01, 2025
Professor Carel le Roux, MBChB, FRCP, FRCPath, PhD / Donna H. Ryan, MD, FTOS - Adopting Modern Management Strategies for Obesity: Treating the Patient, Not the Disease
62 hours 40 mins; April 01, 2025
Neeraj Agarwal, MD, FASCO - Targeted Assault on mCRPC With PARPi Therapies: A VA Tactical Playbook
52 mins; April 01, 2025
Suzanne E. Schindler, MD, PhD - Integrating Biomarker Testing Into Alzheimer’s Disease Workflows: Tools and Strategies for Specialty Care
64 hours 44 mins; April 01, 2025
Alireza Atri, MD, PhD, Scott A. Kaiser, MD - Dialing Up the Power of Alzheimer’s Disease Biomarkers: A Practical Pathway to Earlier Diagnosis
51 mins; March 28, 2025
Angela Fitch, MD, FACP, FOMA - Breaking Through Biases in Obesity Management: Building Competence, Creating Connections, and Empowering Leaders in Primary Care
65 hours 15 mins; March 19, 2025
David Bernstein, MD, MACG, FAASLD, AGAF, FACP - Innovative Approaches to Manage Primary Biliary Cholangitis: Charting New Courses of Care
45 mins; March 14, 2025
Erik Musiek, MD, PhD - Visualizing the Role of Neuroinflammation in the Pathophysiology and Management of Alzheimer’s Disease
28 mins; March 14, 2025
Andrea Necchi, MD - Maximizing Therapeutic Innovations in Bladder Cancer: Expert Strategies for Comprehensive Care Across Disease Stages
84 hours 44 mins; March 11, 2025
Karim Fizazi, MD, PhD - Precision Medicine Crafts a New Story for Metastatic Prostate Cancer: The Next Act of Therapeutic Intensification With AKT Inhibition and Beyond
87 hours 27 mins; March 11, 2025
William Kitchens, MD, PhD, FACS, FAST - Improving Kidney Transplant Access and Equity With Innovative Immunosuppression Strategies
50 mins; March 06, 2025
Gerald Appel, MD, Dana V. Rizk, MD - Advancements in IgA Nephropathy: Discovering the Potential of Complement Pathway Therapies
41 mins; March 05, 2025
Gideon M. Hirschfield, MA, MB, BChir, FRCP, PhD - Individualizing the PBC Care Pathway: From Baseline and Beyond
29 mins; March 05, 2025
Robert M. Hughes, DO / Christina Y. Weng, MD, MBA - Retinal Disease in Emergency Medicine: Timely Recognition and Referral for Specialty Care
63 hours 4 mins; March 03, 2025
Shaji K. Kumar, MD - Restoring Remission in RRMM: Present and Future of Sequential Immunotherapy With GPRC5D-Targeting Options
50 mins; February 25, 2025
R. Scott Turner, MD, PhD / Charles Vega, MD, FAAFP - Diagnose Early, Communicate Clearly: Optimizing Alzheimer’s Outcomes in Primary Care
35 mins; February 24, 2025
Deborah M. Stephens, DO - From Challenges to Changes in R/R CLL: Forging an Academic-Community Practice Alliance for Effective and Safe Sequential Care
63 hours 17 mins; February 24, 2025
Ghassan Abou-Alfa, MD, JD, MBA - Accelerating Innovation In Biliary Tract Cancer: Restructuring Treatment Models With Immunotherapy and Targeted Platforms In Advanced Disease
82 hours 48 mins; February 24, 2025
Heinz-Josef Lenz, MD, FACP - The Personalized Paradigm in CRC Care: Translating Emerging Evidence to Guide Therapy Selection in Advanced Disease
98 hours 9 mins; February 20, 2025
Univ.-Prof. Dr. Peter R. Galle - Elevating Therapeutic Innovation in HCC: Cutting-Edge Strategies Across Disease Settings
43 mins; February 20, 2025
Sheela Rao, MBBS, MD, FRCP - Strengthening the Immunotherapy Paradigm in Advanced SCAC: Established and Emerging Roles of Immune-Based Platforms Across Lines of Therapy
67 hours 0 mins; February 20, 2025
Professor Peter Schmid, FRCP, MD, PhD - Finding the Heat in Cold Tumours: Potential for Perioperative Immunotherapy Strategies in Early Breast Cancer
55 mins; February 17, 2025
Geoffrey Ku, MD - Fortifying the Framework for HER2+ GI Cancers: Precision Treatment Planning With Molecularly Targeted Therapies in GC/GEJC, CRC, and BTC
90 hours 46 mins; February 14, 2025
Lucia M. Novak, MSN, ANP-BC, BC-ADM - Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity
33 mins; February 10, 2025
Prof. Giuseppe Curigliano, MD, PhD - A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical Impact
61 hours 4 mins; February 05, 2025
David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches
47 mins; February 04, 2025
Professor Melanie Davies - Understanding the Individual in Front of You: The Importance of Patient Participation in Weight and Glycaemic Management for People With Type 2 Diabetes
35 mins; January 31, 2025
Vera Bril, BSc, FRCPC, MD - Individualized Treatment for Generalized Myasthenia Gravis: Targeting the Cause and Prioritizing the Patient
33 mins; January 28, 2025
Amy J. McMichael, MD - From Roots to Results: Elevating Alopecia Areata Management
39 mins; January 28, 2025
Milind Desai, MD, MBA, FACC, FAHA, FESC - Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM and Beyond
61 hours 53 mins; January 21, 2025
Kristina M. Deligiannidis, MD - The Future of Care in Postpartum Depression: Comprehensive Strategies for Early Diagnosis and Effective Treatment
44 mins; January 21, 2025
Michelle Kittleson, MD, PhD / Senthil Selvaraj, MD, MS, MA - Don’t Fail Them Now: Bridging Diagnostic and Treatment Gaps in Transthyretin Cardiac Amyloidosis
59 mins; January 21, 2025
Courtney R. Arn, APRN-CNP / Kimberly Halla, MSN, FNP-C - Personalized Care and Tailored Treatment Plans for Gynecologic Cancers: Practical Nurse Guidance on Utilizing Modern Therapeutic Approaches
66 hours 58 mins; January 06, 2025
Professor John G. Gribben, MD, DSc - Crafting Custom Care in CLL: Guidance on Upfront and Sequential Treatment Decisions With Targeted and Immune-Based Platforms
115 hours 18 mins; January 06, 2025
Guillermo Garcia-Manero, MD - Shifting to Higher Standards in MDS: Custom and Innovative Care to Improve Outcomes for Lower- and Higher-Risk Disease
87 hours 23 mins; January 06, 2025
Professor Claire Harrison, DM - Mastering the Art of Myelofibrosis Care: Expert Guidance, Clinical Experience, and Innovation for More Personalized Disease Control
7 mins; January 06, 2025
Vanita R. Aroda, MD - Intensifying Treatment for Type 2 Diabetes According to Current Guidelines: An Office Hours Activity
28 mins; January 03, 2025
Mrinal Gounder, MD - Advancing Therapeutic Control in Desmoid Tumors: Expert Guidance on Modern Diagnostic and Treatment Practices With Gamma Secretase Inhibitors
49 mins; January 03, 2025
Stephen V. Liu, MD - Refining the First Strike Against EGFR-Mutated Advanced NSCLC: Personalizing Frontline Treatment Decisions Amid Increasing Complexity
52 mins; January 03, 2025
Nancy S. Reau, MD - Plugging the Gaps in Hepatitis B and C Care: Understanding and Integrating New Guidelines and Advances in Disease Management
68 hours 10 mins; December 27, 2024
Elena Castro, MD, Karim Fizazi, MD, PhD - What’s Around the Corner in Advanced Prostate Cancer? Candid Conversations to Future Proof Your Practice for Targeted Therapies
39 mins; December 27, 2024
Manmeet S. Ahluwalia, MD, MBA, FASCO - Capitalizing on Personalized Care in IDH-Mutant Gliomas: Expert Guidance on the Use of Biomarker Testing and Targeted Therapies in Real-World Settings
57 mins; December 19, 2024
Ira M. Jacobson, MD - In Pursuit of a Functional Cure for Hepatitis B: Monitoring Effectively, Optimizing Treatment, and Reducing Risk of Complications
81 hours 25 mins; December 12, 2024
William D. Tap, MD - A Joint Effort to Improve Care in Tenosynovial Giant Cell Tumors: Applying a Collaborative Approach When Integrating Targeted Therapies in Practice
88 hours 27 mins; December 12, 2024
Javed Butler, MD, MPH, MBA / Muthiah Vaduganathan, MD, MPH - Experts vs AI: Exploring New Paradigms in Comprehensive Care for Cardio-Renal-Metabolic Diseases
69 hours 59 mins; December 09, 2024
Brooke Looney, PharmD, CSP, Izabela Mazur, PharmD, BCOP - Optimizing PARP Inhibitor Therapy in Veterans With Prostate Cancer: A Practical Guide for VA Pharmacists
57 mins; December 09, 2024
Jason J. Luke, MD, FACP - Resect and Protect Against Melanoma Recurrence: Are You Prepared for the Present and Future of Adjuvant Immunotherapy for Stage II-III Disease?
29 mins; November 29, 2024
Prof. Dr. med. Alexander Drzezga - Alzheimer’s Disease Case Conference: Acquiring New Skills and Visualizing Emerging Strategies for the Era of Amyloid-Targeting Therapies
75 hours 37 mins; November 29, 2024
Kevin Ault, MD, FIDSA, FACOG - The Burden of RSV in Pediatric Populations: Evidence for Reshaping Care and Optimizing Prophylaxis
59 mins; November 22, 2024
Jennifer Chan, MD, MPH - Renewed Optimism for Personalized Care in Advanced Pancreatic and Extra-Pancreatic Neuroendocrine Tumors: The Evolving Role and Clinical Applications of Emerging Strategies to Improve Patient Outcomes
44 mins; November 21, 2024
Fuad El Rassi, MD, Modupe Idowu, MD - A New Script for SCD Care: Guidance on Patient-Centric Treatment Decisions With Innovative Therapeutics
83 hours 59 mins; November 21, 2024
Andrea Cercek, MD - Accelerating Personalized Care in CRC: The Prominent Role of Predictive Biomarkers and Immunotherapy Platforms in Early and Advanced Disease
39 mins; November 12, 2024
James F. Howard Jr., MD, FAAN / Nicholas J. Silvestri, MD, FAAN - Steering Away From Steroids in Myasthenia Gravis Management: The Role of FcRn Inhibitors in the Current Treatment Paradigm
64 hours 3 mins; November 11, 2024
Irl Hirsch, MD, MACP - The New Normal: Digital Technologies for People Living With Insulin-Treated Type 2 Diabetes
56 mins; November 11, 2024
Andrew J. Wagner, MD, PhD - Building the Alliance in Dedifferentiated Liposarcoma: Integrating Personalized, Multidisciplinary Care With Innovative MDM2 Antagonists in Advanced Disease
59 mins; November 11, 2024
Sharon Cohen, MD, FRCPC / Erik Musiek, MD, PhD - Using APOE as a Key in Alzheimer’s Disease Treatment: Unlocking the Amyloid-Targeting Therapy Risk–Benefit Conundrum
60 hours 52 mins; November 11, 2024
Meghan C. Thompson, MD - Building Resilient Care Communities for R/R CLL: Collaborative Sequential Approaches in an Era of Innovative Options
64 hours 53 mins; November 11, 2024
Guillermo E. Umpierrez, MD, CDE, FACP, FACE - Prioritizing Weight Management as a Primary Goal in People With Type 2 Diabetes: An Office Hours Activity
30 mins; November 11, 2024
Kassandra August-Marcucio, DNP, APRN, ACNP-BC, SANE, Grace Cullen, DNP, FNP-BC, AOCNP, PMGT-BC, FPCN - Nurse-Led Strategies for Optimizing PARP Inhibitors in Veterans With Prostate Cancer: Genomic Testing and Practical Care Delivery
55 mins; November 11, 2024
Patrick M. Moriarty, MD, FACP, FACC, FNLA, FESC - Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia
59 mins; November 01, 2024
April W. Armstrong, MD, MPH - Staying on Target Against Moderate to Severe Psoriasis: Strategies for Achieving Sustained Benefits Through TYK2 Inhibition
48 mins; October 28, 2024
Matthew C. Breeggemann, MD / John C. Lieske, MD - Stepping Stones on the Path to a Healthier Future for Patients With Primary Hyperoxaluria Type 1: Expert Perspectives on Ensuring Timely Diagnosis and Appropriate Management
36 mins; October 22, 2024
Guillermo Garcia-Manero, MD - Resetting Standards in MDS: New Principles for Integrating Innovative Therapy Into Risk-Adapted Care
69 hours 38 mins; October 22, 2024
Christopher D. Still, DO, FACP, FTOS - Optimizing Obesity Management Before and After Bariatric Surgery: The Role of Antiobesity Pharmacotherapy to Reduce Weight and Obesity-Related Comorbidities
60 hours 57 mins; October 22, 2024
Arndt Vogel, MD, PhD - Strengthening the Immunotherapy Paradigm in Biliary Tract Cancer: Standardizing Team-Based Strategies With Immune Checkpoint Inhibitors in Advanced Disease
36 mins; October 22, 2024
Professor Stephen Johnston, MA, PhD - How to Make Multifactorial Clinical Decisions in HR+, HER2- EBC and MBC: Guiding Precision Amid Growing Complexity
84 hours 52 mins; October 22, 2024
William G. Wierda, MD, PhD - Exceeding Expectations in CLL: Workshops on Targeted Standards, Sequential Options, and Emerging Therapeutics for Team-Based Care
58 mins; October 04, 2024
Suresh S. Ramalingam, MD, FACP, FASCO - Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC
55 mins; October 04, 2024
Shannon N. Westin, MD, MPH, Ramez N. Eskander, MD - Rethinking and Refining Endometrial Cancer Care in the Modern Age of Precision Medicine: How to Translate Clinical Evidence Into Meaningful Improvements for Patients
66 hours 30 mins; October 02, 2024
Komal Jhaveri, MD, FACP - Embracing Progress, Transforming Treatment, Empowering Patients: Harnessing the Potential of TROP2-Targeted ADC Therapy in TNBC and HR+, HER2- Breast Cancer
74 hours 57 mins; October 02, 2024
Onyema Ogbuagu, MD, FACP, FIDSA - Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers
67 hours 19 mins; October 02, 2024
Natasha B. Leighl, MD, MMSc, FRCPC, FASCO - Navigating Rapid Changes in First- and Later-Line Treatment of EGFR-Mutated NSCLC: A Practical Framework for Optimal Biomarker Testing, Treatment Selection and Sequencing, and Adverse Event Management
59 mins; October 02, 2024
Naval Daver, MD, Tapan Kadia, MD - Opportunity Knocks in AML: Guidance on Achieving Truly Personalized Care in Challenging Populations with Modern Therapeutics
63 hours 4 mins; October 02, 2024
Roy S. Herbst, MD, PhD - Elevating Care in Resectable Stage I-III NSCLC: Targeted Therapy and Immunotherapy at the Forefront of Multimodal Treatment Strategies
63 hours 31 mins; October 02, 2024
Marc S. Sabatine, MD, MPH - Emerging Options for Targeting PCSK9 in Hypercholesterolemia Management: Visualizing New Routes to Individualized Care
44 mins; September 23, 2024
Stephanie L. Graff, MD, FACP, FASCO - Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer: Practical Training on Individualizing CDK4/6 Inhibitor Treatment to Enhance Adherence, Quality of Life, and Outcomes
59 mins; September 23, 2024
Marwan Noel Sabbagh, MD, FAAN, FANA - From Early Detection to Disease Modification: Personalized Approaches to Biomarker Testing and Therapeutic Management of Alzheimer’s Disease
31 mins; September 17, 2024
Hope S. Rugo, MD, FASCO - Exchanging Ideas on How to Navigate Patient-Centric Clinical Decisions in Integration of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer
76 hours 56 mins; September 06, 2024
Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH - Pharmacist-Led RSV Immunization Strategies: Leveraging Trust to Overcome Vaccine Hesitancy
60 hours 56 mins; September 06, 2024
April W. Armstrong, MD, MPH - All Things Considered in Psoriasis Management: Looking at the Role of Biologic Therapies in a Holistic Approach
64 hours 7 mins; September 06, 2024
Sara M. Tolaney, MD, MPH - Critically Focusing Decision-Making and Communication Strategies to Reduce Recurrence in High-Risk HR+, HER2- EBC
65 hours 37 mins; September 06, 2024
John E. Anderson, MD - Conversations With Peers About T2DM: Best Practices for Optimizing Treatment Using Weight Management as a Primary Goal
34 mins; August 28, 2024
Bradley J. Monk, MD, FACS, FACOG - Advancing Immunotherapy: Revolutionizing Cervical Cancer Treatment
35 mins; August 28, 2024
Stacey B. Trooskin, MD, PhD, Robert G Gish, MD - A Modern Take on Hepatitis Immunization: Overcoming Today's Hurdles With Recent Guidelines and Practical Strategies
61 hours 28 mins; August 21, 2024